The specific aim of this project is to design, construct, and evaluate in animal an expandable Laserprobe for treatment of occlusive coronary and peripheral artery disease. The proposed Laserprobe is expected to allow suitable patients to undergo a minimally invasive procedure for the relief of occlusive vessel disease in the legs and in the heart. This can result in substantial benefit to the patient and significant reduction in cost of health care for this ailment. The proposed device provides means for controlled application of heat and pressure to atherosclerotic tissue. The principle of operation involves the transmission of laser energy from source to patient, and the rapid conversion of this energy into controlled thermal energy at distal end of probe. When brought into contact with occlusive tissue, this probe allows heat to be conducted rapidly to this tissue while maintaining a known pressure on the probe-tissue interface. This results in selective and controlled ablation of occlusive tissue with minimal thermal effect on surrounding tissue. The basic design objective is to create an expandable laserprobe which can be introduced percutaneously and which can alone generate a sufficiently large lumen to permit adequate flow through coronary and peripheral arteries. The initial size of the laserprobe is expected to be approximately 1.5 millimeters. The target size of the generated channel is approximately 5 millimeters.

Project Start
1987-09-30
Project End
1988-03-31
Budget Start
1987-09-30
Budget End
1988-03-31
Support Year
1
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Trimedyne, Inc.
Department
Type
DUNS #
City
Santa Ana
State
CA
Country
United States
Zip Code
92705